Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Drug Discovery Informatics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This comprehensive report provides valuable insights and critical information for strategists, marketers, and senior management to assess the drug discovery informatics market. The market is projected to grow from $2.97 billion in 2022 to $3.32 billion in 2023, with a compound annual growth rate (CAGR) of 12.0%. Furthermore, the market is expected to reach $5.21 billion by 2027, exhibiting a CAGR of 11.9%.
Major players in the drug discovery informatics market include Accenture Plc., Certara, Charles River Laboratories Inc., Infosys Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Jubilant Biosys, Selvita, PerkinElmer Inc., International Business Machines Corporation, Boehringer Ingelheim International GmbH, Oracle Corporation, Thermo Fisher Scientific Inc., Albany Molecular Research Inc., and ChemAxon Ltd.
Reasons to Purchase:
- Gain a comprehensive global perspective with detailed coverage of 50+ geographies.
- Understand the market's response to COVID-19 and its impact as the virus abates.
- Assess the direct and indirect effects of the Russia-Ukraine war on agriculture, energy, mineral commodity supply, and the market.
- Measure the influence of high global inflation on market growth.
- Develop regional and country-specific strategies based on localized data and analysis.
- Identify investment opportunities in growth segments.
- Outperform competitors using forecast data and insights into market drivers and trends.
- Understand customer dynamics based on the latest market shares.
- Benchmark performance against key competitors.
- Support internal and external presentations with reliable high-quality data and analysis.
Drug discovery informatics involves the development of systems that can efficiently handle large volumes of clinical trial and treatment data, facilitating faster and more efficient research and development of new treatments.
The services offered in the drug discovery informatics market include in-house and outsourced solutions. In-house solutions refer to computer programs developed by companies themselves and used for their business operations. Various modalities, such as cloud-based systems and in-campus applications, are utilized for tasks like data sequencing, molecular docking, identification and validation, and target data analysis. Pharmaceutical companies, contract research organizations, and biotechnology companies are the primary end-users of these solutions.
Technological advancements are driving the drug discovery informatics market, with major companies focusing on developing innovative solutions to enhance their market position. In a recent merger, Norstella, a pharmaceutical consultancy services and solutions provider, joined forces with Citeline, a provider of pharmaceutical intelligence and research and development. This collaboration aims to accelerate innovation in the drug development process, leading to faster availability of medicines for patients.
North America dominated the drug discovery informatics market in 2022, while Asia-Pacific is expected to witness the fastest growth in the forecast period. The regions covered in the market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Key countries analyzed in the report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The increasing prevalence of chronic diseases is a significant factor driving the growth of the drug discovery informatics market. Chronic illnesses, which last for a year or longer and require ongoing medical treatment, affect a substantial portion of the population. Drug discovery informatics systems enable researchers to study complex molecular changes associated with disease progression and drug response, leading to comprehensive models of healthy, diseased, and treated states.
The World Health Organization reports that non-communicable diseases (NCDs) are expected to cause 41 million deaths in 2022, accounting for 74% of all global deaths. Cardiovascular diseases, cancer, chronic respiratory disorders, and diabetes are among the leading causes. This rising prevalence of chronic diseases underscores the importance of drug discovery informatics in advancing research and development efforts.
The drug discovery informatics market encompasses a wide range of services, including literature databases, chemical and biological databases, predictive analytics, structural analysis, and data analytics in genomics and proteomics. The market also includes the sales of continuous integration (CI) design tools and pharmacophore modeling tools used in drug discovery informatics. The market value represents revenues generated by providers through sales, grants, or donations, and it includes related goods and services.
As the drug discovery informatics market continues to evolve, it presents ample opportunities for companies to leverage technological advancements and address the growing demand for efficient and effective research and development in the pharmaceutical industry.
Key Topics Covered:
1. Executive Summary
2. Drug Discovery Informatics Market Characteristics
3. Drug Discovery Informatics Market Trends And Strategies
4. Drug Discovery Informatics Market - Macro Economic Scenario
4.1. COVID-19 Impact On Drug Discovery Informatics Market
4.2. Ukraine-Russia War Impact On Drug Discovery Informatics Market
4.3. Impact Of High Inflation On Drug Discovery Informatics Market
5. Drug Discovery Informatics Market Size And Growth
5.1. Global Drug Discovery Informatics Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Drug Discovery Informatics Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Drug Discovery Informatics Market Segmentation
6.1. Global Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- In-House
- Outsourced
6.2. Global Drug Discovery Informatics Market, Segmentation By Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Cloud-Based Systems
- In-Campus
6.3. Global Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Data Sequencing
- Molecular Docking
- Identification And Validation
- Target Data Analysis
6.4. Global Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Pharmaceutical Companies
- Contract Research Organization
- Bio-Technology Companies
7. Drug Discovery Informatics Market Regional And Country Analysis
7.1. Global Drug Discovery Informatics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Drug Discovery Informatics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/hqocb5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
